BioHealth News Archive
Register for Catalyze Pre-IND Webinar on May 18th @ 12 PM ET
What is a pre-IND? Why have a pre-IND? What goes into preparing for a pre-IND? And, what documents are required? All of these questions…
Read More
Douglas Falk, CEO & Co-founder of Vita Therapeutics Visits BioTalk
Vita Therapeutics CEO & Co-founder Douglas Falk chats with Rich Bendis to discuss his career, their platforms, and moving into the University of Maryland…
Read More
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
GAITHERSBURG, Md., May 16, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into a definitive agreement with…
Read More
Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa
ROCKVILLE, Md., May 16, 2022 /PRNewswire/ -- Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and…
Read More
Sponsored Deloitte: Why now could be a great time to start preparing for an IPO | Crain’s New York Business
No question about it—2021 was a banner year for initial public offerings. Nasdaq data indicates 1,033 IPOs last year, more than double 2020’s 471.…
Read More
The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development
MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe), announces that it has expanded its license to the…
Read More
IndyGeneUS AI Awarded Grant Funding through QuickFire Challenge
IndyGeneUS plans to use the grant funding from Johnson & Johnson Innovation to Scale Blockchain-secured Genomic Data Marketplace and Proprietary GenēUS™ Discovery Platform WASHINGTON, May…
Read More
Another Federal Regional Cluster Funding Opportunity Emerges
By: Brian Darmody, Chief Strategy Officer, AURP: Building Communities of Innovation May 10, 2022 Sometime this September, the US Economic and Development Agency (EDA)…
Read More
QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A. | Business Wire
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a 96%…
Read More
Qiagen N.V. – QIAGEN acquires majority stake in enzymes provider BLIRT S.A.
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has signed agreements to acquire a…
Read More
Cartesian Therapeutics to Present Late-Breaking Data from Phase 1/2a Trial of RNA CAR T-cell Therapy in Patients with Generalized Myasthenia Gravis
- Data Presentation Today at 14th Myasthenia Gravis Foundation of America International Conference on Myasthenia and Related Disorders in Miami - GAITHERSBURG, Md., May 10, 2022 /PRNewswire/ --…
Read More
Emmes launches Advantage eClinical as a standalone cloud native clinical technology platform
The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data…
Read More
BioBuzz Media Completes Inaugural University of Maryland Blockchain Accelerator Program
New blockchain talent marketplace seeks to solve hiring and diversity challenges in the rapidly growing biotech industry. BALTIMORE, MD (May 10, 2022) – BioBuzz…
Read More
University of Maryland Adds $67M IDEA Factory To Its Innovation Ecosystem
COLLEGE PARK, Md., May 10, 2022 /PRNewswire/ -- The University of Maryland today dedicated the new E.A. Fernandez IDEA (Innovate, Design and Engineer for…
Read More
ISPOR 2022 May 15-18, 2022 – Washington, DC, USA Area and Virtual
We are very excited for this year’s conference theme! Our theme will be a “green thread” that is woven throughout our many sessions to…
Read More